Overall (n=222) | |
Plasma biomarkers | |
LRP1 (ng/mL), median (Q1, Q3) | 1080 (796, 1390) |
AGP (mg/dL), median (Q1, Q3) | 91.9 (69.0, 118) |
CRP (mg/L), median (Q1, Q3) | 0.820 (0.284, 2.84) |
sCD14 (ng/mL), median (Q1, Q3) | 1760 (1470, 2120) |
Ferritin (ng/mL), median (Q1, Q3) | 13.8 (7.17, 25.1) |
Zinc (mg/L), median (Q1, Q3) | 0.760 (0.68, 0.84) |
Faecal biomarkers | |
MPO (ng/mL), median (Q1, Q3) | 1720 (796, 3720) |
Neopterin (nmol/L), median (Q1, Q3) | 1240 (567, 2690) |
A1AT (mg/g), median (Q1, Q3) | 0.294 (0.13, 0.52) |
Calprotectin (µg/g), median (Q1, Q3) | 372 (208, 677) |
Reg1B (µg/mL), median (Q1, Q3) | 48.8 (13.9, 88.4) |
LCN2 (μg/g), median (Q1, Q3) | 134 (41.6, 280) |
AGP, alpha-1-acid glycoprotein; CRP, C-reactive protein; LCN2, lipocalin-2; LRP1, low-density lipoprotein receptor-related protein-1; MPO, myeloperoxidase.